Interaction between furosemide and the converting enzyme inhibitor benazepril in healthy volunteers

Comparison of Different Methods for Decision-Making in Bioequivalence Assessment

Daniel Mandallaz, Jochen Mau · Biometrics · 1981 · 143 citations

Pharmacy, Biostatistics, Pharmacokinetics +11

Implications of intraindividual variability in bioavailability studies of furosemide

A. Grahn�n, Margareta Hammarlund, Thomas Lundqvist · European Journal of Clinical Pharmacology · 1984 · 73 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

An aid to decision-making in bioequivalence assessment

H. Fluchler, J. Hirtz, Hubert Anton Moser · Journal of Pharmacokinetics and Biopharmaceutics · 1981 · 41 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacology +12

Haemodynamic and pharmacological effects of the converting enzyme inhibitor CGS 14824A in normal volunteers

M. D. Schaller, J. Nussberger, Bernard Waeber et al. · European Journal of Clinical Pharmacology · 1985 · 33 citations

Medicine, Pharmacology, Pharmacotherapy +10

Determination of a new angiotensin converting enzyme inhibitor and its active metabolite in plasma and urine by gas chromatography-mass spectrometry

G. Kaiser, Roland Ackermann, W. Dieterle et al. · Journal of Chromatography B Biomedical Sciences and Applications · 1987 · 31 citations

Life Sciences, Pharmaceutical Analysis, Pharmacology +11